Simply find the best possible online shopping La Manufacture deals
Shop La Manufacture products and compare prices and listings on popular online marketplaces.
As global effort to fight climate change intensifies, the challenge for battery manufacturers and their supply chains is to find ways to meet the rapidly growing demand for electric vehicles (EVs). To help meet this challenge, a small start-up business in Finland, Sensmet, has developed an online monitoring technology that promises a step-change improvement in both the manufacturing and recycling of battery metals. Sensmet CEO Dr Toni Laurila, explains: “We bring the analytical performance equivalence of laboratory ICP-OES next to the production process where real-time metal concentration results are acutely needed. In comparison with laboratory analysis, Sensmet’s technology provides robust, fully automated online measurement, which offers enormous advantages for process management and quality control.”
Traditionally, battery metal manufacturers have had to rely on batch sampling and laboratory analysis in order to control their processes, but typically this incurs a delay of 4–10 hours. Sensmet has therefore developed a breakthrough online technology; Micro-Discharge Optical Emission Spectroscopy µDOES®, which is able to measure multiple metals, including alkali metals, such as any battery metal and their impurities, in real-time.
Laboratory analysis can take several hours for a sample to be collected and analysed in a laboratory, which means that process…
Age-related macular degeneration (AMD) is a degenerative eye condition that affects approximately ¼ of the population. Particularly in the western world, it is the most frequent cause of blindness in humans. In most cases, the chronic progression of the retinal condition is not curable, as the window of opportunity in which any therapeutic action can be taken is very small. Fraunhofer researchers have now developed a new method for the production and clinical application of stem-cell-based retinal implants, which could contribute towards the successful treatment of AMD. Their approach thereby is to replace damaged tissue with stem-cell-based transplants.
In addition to the further development of the manufacturing process, one of the greatest current challenges in working with human induced pluripotent stem cells (hiPSC) is the long-term storage and the transport of the cells. Within the framework of the “KryoRet” project, the Fraunhofer institutes for Biomedical Engineering IBMT, for Silicate Research ISC, and for Surface Engineering and Thin Films IST, together with the Fraunhofer Translational Center Regenerative Therapies TLC-RT, therefore investigated the technical and biotechnological prerequisites involved in enabling hiPSC-based retinal implants to be manufactured more efficiently and stored…
Apple plans to increase the share of its products manufactured in India to 25%. This was reported by Reuters, citing a statement by India's commerce minister on January 23.
Emphasizing that many large companies have chosen the promising Indian market, Piyush Goyal said: "Apple is another success story. They already produce 5-7% of their products in India. If I am not mistaken, they want to increase this share up to 25%. Their latest models have been launched in India."
Minister Goyal did not specify the time frame in which Apple intends to realize these goals.
The trend to pull production out of China amid a slowing economy and rising tensions has been particularly strong recently. India, as well as Vietnam and Taiwan, are among the countries where major IT corporations are moving their Chinese production. According to India's Minister of Electronics and Information Technology, Apple's exports to India alone totaled $1 billion in December. Apple started manufacturing in India in 2017, selecting Wistron and Foxconn as contractors. Meanwhile, Foxconn intends to quadruple the number of workers at its iPhone manufacturing plant in India over the next two years. JP Morgan estimates that by 2025, 25% of Apple products will be…